BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36520380)

  • 41. The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases.
    Deng X; Zheng Z; Lin B; Su H; Chen H; Fei S; Fei Z; Zhao L; Jin X; Xie CY
    BMC Cancer; 2017 Jan; 17(1):42. PubMed ID: 28068937
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Brain metastases in patients with ALK+ non-small cell lung cancer: clinical symptoms, treatment patterns and economic burden.
    Guérin A; Sasane M; Zhang J; Culver KW; Dea K; Nitulescu R; Wu EQ
    J Med Econ; 2015 Apr; 18(4):312-22. PubMed ID: 25565443
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Understanding the patient experience and treatment benefits in patients with non-small-cell lung cancer with brain metastasis.
    Cella D; Wen PY; Ervin C; Vallow S; Gilloteau I; DeMuro C; Mordin M; Chassot Agostinho A; Dine J
    Cancer Med; 2023 Jun; 12(12):13637-13648. PubMed ID: 37306665
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk factors of brain metastases in completely resected pathological stage IIIA-N2 non-small cell lung cancer.
    Ding X; Dai H; Hui Z; Ji W; Liang J; Lv J; Zhou Z; Yin W; He J; Wang L
    Radiat Oncol; 2012 Jul; 7():119. PubMed ID: 22846375
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patient selection for whole brain radiotherapy (WBRT) in a large lung cancer cohort: Impact of a new Dutch guideline on brain metastases.
    Hendriks LE; Troost EG; Steward A; Bootsma GP; De Jaeger K; van den Borne BE; Dingemans AM
    Acta Oncol; 2014 Jul; 53(7):945-51. PubMed ID: 24754845
    [TBL] [Abstract][Full Text] [Related]  

  • 46. EGFR, KRAS, BRAF, and HER-2 molecular status in brain metastases from 77 NSCLC patients.
    Villalva C; Duranton-Tanneur V; Guilloteau K; Burel-Vandenbos F; Wager M; Doyen J; Levillain PM; Fontaine D; Blons H; Pedeutour F; Karayan-Tapon L
    Cancer Med; 2013 Jun; 2(3):296-304. PubMed ID: 23930206
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inverse spatial distribution of brain metastases and white matter hyperintensities in advanced lung and non-lung cancer patients.
    Quattrocchi CC; Errante Y; Mallio CA; Carideo L; Scarciolla L; Santini D; Tonini G; Zobel BB
    J Neurooncol; 2014 Nov; 120(2):321-30. PubMed ID: 25048530
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): implications for PCI optimization in limited-stage small cell lung cancer.
    Chu X; Li S; Xia B; Chu L; Yang X; Ni J; Zou L; Li Y; Xie C; Lin J; Zhu Z
    Radiat Oncol; 2019 Sep; 14(1):171. PubMed ID: 31533763
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genes associated with increased brain metastasis risk in non-small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non-small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036).
    Wang H; Ou Q; Li D; Qin T; Bao H; Hou X; Wang K; Wang F; Deng Q; Liang J; Zheng W; Wu X; Wang X; Shao YW; Mou Y; Chen L
    Cancer; 2019 Oct; 125(20):3535-3544. PubMed ID: 31287555
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and mechanism study of cordycepin against brain metastases of small cell lung cancer based on zebrafish.
    Zhang SR; Pan M; Gao YB; Fan RY; Bin XN; Qian ST; Tang CL; Ying HJ; Wu JQ; He MF
    Phytomedicine; 2023 Jan; 109():154613. PubMed ID: 36610112
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exon 19 deletion of epidermal growth factor receptor is associated with prolonged survival in brain metastases from non-small-cell lung cancer.
    Li H; Zhang X; Cao J; Su P; Lian J; Song X; Yang W; Han S; Xi Y; Wang Y
    Tumour Biol; 2015 Dec; 36(12):9251-8. PubMed ID: 26091796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk of hippocampal metastases in small cell lung cancer patients at presentation and after cranial irradiation: a safety profile study for hippocampal sparing during prophylactic or therapeutic cranial irradiation.
    Kundapur V; Ellchuk T; Ahmed S; Gondi V
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):781-6. PubMed ID: 25752392
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A systematic review of risk factors for brain metastases and value of prophylactic cranial irradiation in non-small cell lung cancer.
    Sun DS; Hu LK; Cai Y; Li XM; Ye L; Hou HY; Wang CH; Jiang YH
    Asian Pac J Cancer Prev; 2014; 15(3):1233-9. PubMed ID: 24606446
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European experts.
    Putora PM; Fischer GF; Früh M; Califano R; Faivre-Finn C; Van Houtte P; McDonald F; Nestle U; Dziadziuszko R; Le Pechoux C; Ramella S; Belderbos J; Slotman BJ; Troost EGC; Peeters S; Widder J; Pöttgen C; Reck M; Blackhall F; Cappuzzo F; Besse B; Novello S; Garrido P; Felip E; O'Brien M; Paz Ares L; de Marinis F; Westeel V; De Ruysscher D
    Radiother Oncol; 2020 Aug; 149():84-88. PubMed ID: 32445987
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epidermal growth factor receptor mutation and pattern of brain metastasis in patients with non-small cell lung cancer.
    Baek MY; Ahn HK; Park KR; Park HS; Kang SM; Park I; Kim YS; Hong J; Sym SJ; Park J; Lee JH; Shin DB; Cho EK
    Korean J Intern Med; 2018 Jan; 33(1):168-175. PubMed ID: 27093978
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Zebrafish xenograft model for studying mechanism and treatment of non-small cell lung cancer brain metastasis.
    Fan RY; Wu JQ; Liu YY; Liu XY; Qian ST; Li CY; Wei P; Song Z; He MF
    J Exp Clin Cancer Res; 2021 Nov; 40(1):371. PubMed ID: 34801071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analyses of distribution and dosimetry of brain metastases in small cell lung cancer with relation to the neural stem cell regions: feasibility of sparing the hippocampus in prophylactic cranial irradiation.
    Zhao L; Shen Y; Guo JD; Gu HL; Yu W; Wang JM; Lv CX; Liu J; Cai XW; Fu XL
    Radiat Oncol; 2017 Jul; 12(1):118. PubMed ID: 28709456
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Real-world utilization of EGFR TKIs and prognostic factors for survival in EGFR-mutated non-small cell lung cancer patients with brain metastases.
    Yu X; Sheng J; Pan G; Fan Y
    Int J Cancer; 2021 Sep; 149(5):1121-1128. PubMed ID: 33970485
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Diagnostic Value of Transbronchial Ultrasound-guided Needle Aspiration Biopsy in the Diagnosis of Small Cell Lung Cancer and Non-small Cell Lung Cancer].
    Tan X; Liu B; Wang R; Zhang Y
    Zhongguo Fei Ai Za Zhi; 2020 Jun; 23(6):466-471. PubMed ID: 32517451
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The incidence and clinical impact of bone metastases in non-small cell lung cancer.
    Kuchuk M; Kuchuk I; Sabri E; Hutton B; Clemons M; Wheatley-Price P
    Lung Cancer; 2015 Aug; 89(2):197-202. PubMed ID: 26003503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.